Thomas McGauley
Fortune : 94 960 $ au 31/05/2026
Fortune : 94 960 $ au 31/05/2026
Thomas A. McGauley is currently a Member at Danforth Advisors LLC since 2021 and Chief Accounting Officer at Tenax Therapeutics, Inc. starting in 2024.
Formerly, Mr. McGauley was Chief Financial Officer & Accounting Director at Galectin Therapeutics, Inc. in 2012.
Education includes undergraduate studies at Stonehill College, Inc.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/04/2026 | 8 000 ( 0,03% ) | 94 960 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| TENAX THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 03/12/2024 |
Danforth Advisors LLC
Danforth Advisors LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic advisory and operational execution services for corporate, clinical & commercial sectors | Corporate Officer/Principal | 01/07/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
| GALECTIN THERAPEUTICS INC. | Directeur Financier/CFO | 01/07/2013 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Tenax Therapeutics, Inc.
Tenax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes pharmaceutical therapeutic products | Health Technology |
Galectin Therapeutics, Inc.
Galectin Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs to combat various diseases | Health Technology |
Stonehill College, Inc.
Stonehill College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Danforth Advisors LLC
Danforth Advisors LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic advisory and operational execution services for corporate, clinical & commercial sectors | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national